Bristol Myers and Celgene are being sued in an antitrust suit, alleging they used fraud, sham litigation, and reverse ...

PM360 is honored to announce its Lifetime Achievement Recipient—Dr. Sol J. Barer of Teva Pharmaceuticals—who will be recognized at the 17th annual Trailblazer Awards in NYC on September 30.

Two months after Bristol Myers Squibb fended off a lawsuit which accused the drugmaker of using illegal tactics to protect ...

Cigna sued Bristol Myers Squibb on Tuesday, accusing the drugmaker of violating U.S. antitrust law by keeping generic ...

Cigna sued Bristol Myers Squibb on Tuesday, accusing the drugmaker of violating U.S. antitrust law by keeping generic ...

Cigna sued Bristol Myers on Tuesday, accusing the drugmaker of violating federal antitrust law by maintaining a monopoly over ...

In this GEN panel discussion, three experts in cell and gene therapy development will share lessons and strategies learned ...

Phase 2 trial results support Isa-KRd as a standard treatment option for patients with high-risk, newly diagnosed multiple myeloma, according to researchers.

Discover why BeOne Medicines (BEIGF) is a strong Buy with growth driven by Brukinsa, Tevimbra, and a promising oncology ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety and promising objective response rates in patients with few treatment choices ...

Bachleda, PharmD, MBA appointed as independent member of the Board of Directors ; David Shook, MD appointed as Chief Medical Officer, Mark ...

View today's Celgene Corporation stock price and latest CELG news and analysis. Create real-time notifications to follow any changes in the live stock price.